HPW/MCM-41 catalytic Simmons-Smith cyclopropanation of olefins for synthesis of high-energy–density fuel
•HPW/MCM-41 catalyst can catalyze the Simmons-Smith cyclopropanation.•Cyclopropanation activity and the acid site amounts have a positive correlation.•HPW/MCM-41 is an efficient catalyst for the synthesis of high-energy–density fuel. Simmons-Smith cyclopropanation commonly promoted by CF3COOH is one...
Gespeichert in:
Veröffentlicht in: | Chemical engineering science 2024-01, Vol.283, p.119366, Article 119366 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •HPW/MCM-41 catalyst can catalyze the Simmons-Smith cyclopropanation.•Cyclopropanation activity and the acid site amounts have a positive correlation.•HPW/MCM-41 is an efficient catalyst for the synthesis of high-energy–density fuel.
Simmons-Smith cyclopropanation commonly promoted by CF3COOH is one important method for transforming olefin into high-energy–density cyclopropyl fuel, but it brings problems such as high cost and harm to environment. In this work, a series of highly active solid acid catalysts HPW/MCM-41 is prepared by impregnation method for the cyclopropanation of dicyclopentadiene. The composition, structural and acidity of catalyst were characterized by TEM, XRD, NH3-TPD, etc. The 5 % HPW/MCM-41 contains more Dawson-type P2W18 (H6P2W18O62) and defective-type P2W21 (H6P2W21O71) that can provide the most abundant acid sites. This catalyst shows the best catalytic activity, the conversion and bicyclic product selectivity for cyclopropanation of dicyclopentadiene are 93.4 % and 55.7 %, respectively, both higher than that of CF3COOH. Moreover, such catalyst shows good catalytic activity for several olefin substrates, and can be recycled in several runs. This work provides a green and efficient catalyst for cyclopropanation reactions for synthesis of high-energy–density fuel, pesticide and medicine. |
---|---|
ISSN: | 0009-2509 1873-4405 |
DOI: | 10.1016/j.ces.2023.119366 |